Table 3

Costs, number of admissions and length of stay for hospitalisation associated with moyamoya disease in urban China during 2013–2016

20132014201520162013–2016
Patient no2484285659841987
Inpatient, n (%)129 (52.02)263 (61.45)335 (59.29)653 (66.36)1262 (63.51)
Per-capita cost ($)*4741.32 (5067.00)11 422.44 (34820.59)12 723.19 (39669.01)9618.58 (25678.70)11 049.07 (32161.48)
Per-capita medication cost ($)*1645.12 (2965.64)4446.72 (18868.08)5244.98 (21921.67)3164.46 (11253.66)4057.76 (16377.72)
Per-episode cost ($)*3920.71 (4460.46)9186.86 (30171.52)9981.90 (25890.00)7433.06 (20921.19)7945.26 (23011.65)
Per-episode medication cost ($)*1725.37 (2807.55)4237.27 (18353.06)4867.23 (15660.95)2826.80 (10266.80)3434.54 (12971.42)
Average no of hospital admissions1.20 (0.55)1.24 (0.72)1.27 (1.01)1.30 (0.91)1.39 (1.24)
Average length of stay (days)15.47 (23.36)16.23 (20.11)15.59 (22.80)18.52 (27.40)18.69 (31.04)
  • Mean (SD).

  • *Costs were discounted by Consumer Price Index (CPI) in each year to 2016 and converted into US dollars based on the 2016 RMB to US dollar exchange rate (period average). The CPI and exchange rate were from 2017 China statistical yearbook.